Risk factors of recurrent common bile duct stones after ERCP
10.3760/cma.j.issn.1007-5232.2010.11.005
- VernacularTitle:胆总管结石十二指肠镜治疗后复发因素研究
- Author:
Xiufen TANG
;
Xu REN
;
Chunlan ZHU
;
Xiaohong XU
- Publication Type:Journal Article
- Keywords:
Cholangiopancreatography,endoscopic retrograde;
Choledocholithiasis;
Recurrence;
Risk factors
- From:
Chinese Journal of Digestive Endoscopy
2010;27(11):572-575
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the risk factors of recurrent common bile duct (CBD) stones after treatment with endoscopic retrograde cholangiopancreatography (ERCP). Methods A total of 802 patients with CBD stone and with complete follow-up data were recruited to the study, among which 297 patients were accompanied with gallstone, 222 patients having undergone cholecystectomy before ERCP and 283 having no gallstones. The CBD stone recurrent frequency and the possible risk factors were calculated with uni- and multi-variate logistic regression analysis. Results The patients were followed up at a mean duration of 84. 8 months, and CBD stone re-occurred in 92 (11.5%). Both uni- and multivariate analysis showed gallstones, CBD larger than 1.5 cm, endoscopic mechanical lithotrity (EML) and angle of bile duct less than 120° were risk factors of recurrence. Multivariate analysis showed cholesterol stones, cholangeal stricture or sphincter of Oddis dysfunction (SOD) were all risk factors for reccurrence. Univariate analysis revealed that history of cholecystectomy or Billroth Ⅱ gastrectomy, stones larger than 1.5 cm and multiple stones were risk factors of recurrence. Conclusion For those with CBD stones undergoing ERCP, gallstone,common bile larger than 1. 5cm, EML and the angle of CBD less than 120° are major risk factors of recurrence. History of cholecystectomy and Billroth Ⅱ gastrectomy, SOD, large CBD stone ( ≥1.5 cm), cholesterol stone and multiple stones are also associating risk factors.
